GRIP1 and melanoma: Thus, regulating the expression of GRIPs may increase the efficacy of ICB in melanoma, and our results also revealed the potential value of the GRIP signature to enhance the effect of immunotherapeutic, chemotherapeutic, and targeted drugs.